title: Is FISH floating or still swimming in the lung cancer ocean?
authors.affiliation: Department of Medical Oncology, Istituto Toscano Tumori-Ospedale Civile di Livorno, Livorno, Italy. Electronic address: f.cappuzzo@googlemail.com.
authors.forename: F
authors.initials: F
authors.lastname: Cappuzzo
authors.affiliation: Departments of Medicine/Medical Oncology; Pathology, University of Colorado Denver, Aurora, USA.
authors.forename: D R
authors.initials: DR
authors.lastname: Camidge
authors.affiliation: Departments of Medicine/Medical Oncology; Pathology, University of Colorado Denver, Aurora, USA.
authors.forename: M
authors.initials: M
authors.lastname: Varella-Garcia
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D066246:ErbB Receptors / Q000235:genetics* / Q000378:metabolism; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D015201:Meta-Analysis as Topic; D025202:Molecular Diagnostic Techniques; D009154:Mutation; D011799:Quinazolines / Q000627:therapeutic use; D055752:Small Cell Lung Carcinoma / Q000175:diagnosis* / Q000188:drug therapy / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors; D000077156:Gefitinib